C1q 抗体 (FITC)
Quick Overview for C1q 抗体 (FITC) (ABIN2477784)
抗原
See all C1q 抗体适用
宿主
克隆类型
标记
应用范围
-
-
产品特性
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
免疫原
- Human C1q, purified from plasma
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 10 mg/mL
-
-
-
Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." in: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
: "Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents." in: Blood, Vol. 103, Issue 7, pp. 2738-43, (2004) (PubMed).
: "Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity." in: Journal of neuroimmunology, Vol. 137, Issue 1-2, pp. 12-8, (2003) (PubMed).
: "
-
Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." in: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
-
-